BioLife Solutions Return On Asset vs. Net Income
| BLFS Stock | USD 26.35 1.04 4.11% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.42 | 0.59 |
|
|
For BioLife Solutions profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioLife Solutions to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioLife Solutions utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioLife Solutions's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioLife Solutions over time as well as its relative position and ranking within its peers.
BioLife Solutions' Revenue Breakdown by Earning Segment
Check out Trending Equities.
BioLife Solutions Revenue Breakdown by Earning Segment
By analyzing BioLife Solutions' earnings estimates, investors can diagnose different trends across BioLife Solutions' analyst sentiment over time as well as compare current estimates against different timeframes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (0.38) | Revenue Per Share | Quarterly Revenue Growth 0.312 | Return On Assets |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioLife Solutions Net Income vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioLife Solutions's current stock value. Our valuation model uses many indicators to compare BioLife Solutions value to that of its competitors to determine the firm's financial worth. BioLife Solutions is rated fifth in return on asset category among its peers. It is rated second in net income category among its peers . At this time, BioLife Solutions' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value BioLife Solutions by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BioLife Net Income vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
BioLife Solutions |
| = | -0.0073 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
BioLife Solutions |
| = | (20.18 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
BioLife Net Income Comparison
BioLife Solutions is currently under evaluation in net income category among its peers.
BioLife Solutions Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioLife Solutions, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioLife Solutions will eventually generate negative long term returns. The profitability progress is the general direction of BioLife Solutions' change in net profit over the period of time. It can combine multiple indicators of BioLife Solutions, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 27.6 K | 29 K | |
| Operating Income | -6.4 M | -6.7 M | |
| Net Loss | -18.2 M | -17.3 M | |
| Income Tax Expense | -34.2 K | -35.9 K | |
| Income Before Tax | -10.3 M | -9.8 M | |
| Total Other Income Expense Net | -3.9 M | -3.7 M | |
| Net Loss | -10.2 M | -10.8 M | |
| Non Operating Income Net Other | 5.7 M | 6 M | |
| Net Loss | -125.8 M | -119.5 M | |
| Interest Income | 66.7 K | 63.4 K | |
| Net Interest Income | -647.1 K | -614.7 K | |
| Change To Netincome | 132 M | 138.6 M | |
| Net Loss | (0.39) | (0.41) | |
| Income Quality | (0.38) | (0.36) | |
| Net Income Per E B T | 1.59 | 2.03 |
BioLife Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioLife Solutions. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioLife Solutions position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioLife Solutions' important profitability drivers and their relationship over time.
BioLife Solutions Earnings Estimation Breakdown
The calculation of BioLife Solutions' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of BioLife Solutions is estimated to be 0.015 with the future projection ranging from a low of 0.0 to a high of 0.02. Please be aware that this consensus of annual earnings estimates for BioLife Solutions is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.00 Lowest | Expected EPS | 0.02 Highest |
BioLife Solutions Earnings Projection Consensus
Suppose the current estimates of BioLife Solutions' value are higher than the current market price of the BioLife Solutions stock. In this case, investors may conclude that BioLife Solutions is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and BioLife Solutions' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 10 | 36.2% | 0.0 | 0.015 | -0.38 |
BioLife Solutions Earnings per Share Projection vs Actual
Actual Earning per Share of BioLife Solutions refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering BioLife Solutions predict the company's earnings will be in the future. The higher the earnings per share of BioLife Solutions, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.BioLife Solutions Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as BioLife Solutions, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of BioLife Solutions should always be considered in relation to other companies to make a more educated investment decision.BioLife Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact BioLife Solutions' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-06 | 2025-09-30 | -0.0113 | 0.042 | 0.0533 | 471 | ||
2025-08-07 | 2025-06-30 | -0.03 | -0.33 | -0.3 | 1000 | ||
2025-05-07 | 2025-03-31 | -0.035 | 0.0355 | 0.0705 | 201 | ||
2025-02-26 | 2024-12-31 | -0.0567 | -0.016 | 0.0407 | 71 | ||
2024-11-12 | 2024-09-30 | -0.09 | -0.0175 | 0.0725 | 80 | ||
2024-08-08 | 2024-06-30 | -0.14 | -0.5 | -0.36 | 257 | ||
2024-05-09 | 2024-03-31 | -0.28 | -0.23 | 0.05 | 17 | ||
2024-02-29 | 2023-12-31 | -0.34 | -0.3 | 0.04 | 11 | ||
2023-11-09 | 2023-09-30 | -0.37 | -0.3 | 0.07 | 18 | ||
2023-08-08 | 2023-06-30 | -0.2 | -0.23 | -0.03 | 15 | ||
2023-05-10 | 2023-03-31 | -0.21 | -0.32 | -0.11 | 52 | ||
2023-03-16 | 2022-12-31 | -0.17 | -1.15 | -0.98 | 576 | ||
2022-11-09 | 2022-09-30 | -0.17 | -0.23 | -0.06 | 35 | ||
2022-08-09 | 2022-06-30 | -0.21 | -0.06 | 0.15 | 71 | ||
2022-05-09 | 2022-03-31 | -0.25 | -0.17 | 0.08 | 32 | ||
2022-02-28 | 2021-12-31 | -0.17 | -0.37 | -0.2 | 117 | ||
2021-11-11 | 2021-09-30 | -0.09 | 0.0018 | 0.0918 | 102 | ||
2021-08-12 | 2021-06-30 | -0.07 | -0.12 | -0.05 | 71 | ||
2021-05-13 | 2021-03-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2021-03-22 | 2020-12-31 | -0.02 | -0.06 | -0.04 | 200 | ||
2020-11-05 | 2020-09-30 | -0.02 | -0.08 | -0.06 | 300 | ||
2020-08-06 | 2020-06-30 | -0.04 | -0.7 | -0.66 | 1650 | ||
2020-05-14 | 2020-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2020-03-11 | 2019-12-31 | -0.02 | 0.02 | 0.04 | 200 | ||
2019-11-12 | 2019-09-30 | 0.02 | -0.03 | -0.05 | 250 | ||
2019-08-08 | 2019-06-30 | 0.02 | 0.04 | 0.02 | 100 | ||
2019-05-09 | 2019-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2019-03-14 | 2018-12-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2018-11-08 | 2018-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2018-08-09 | 2018-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2018-05-10 | 2018-03-31 | -0.01 | -0.01 | 0.0 | 0 | ||
2018-03-08 | 2017-12-31 | -0.04 | -0.05 | -0.01 | 25 | ||
2017-11-09 | 2017-09-30 | -0.06 | -0.03 | 0.03 | 50 | ||
2017-08-10 | 2017-06-30 | -0.04 | -0.06 | -0.02 | 50 | ||
2017-05-11 | 2017-03-31 | -0.05 | -0.04 | 0.01 | 20 | ||
2017-03-09 | 2016-12-31 | -0.07 | -0.26 | -0.19 | 271 | ||
2016-11-10 | 2016-09-30 | -0.08 | -0.08 | 0.0 | 0 | ||
2016-08-11 | 2016-06-30 | -0.08 | -0.11 | -0.03 | 37 | ||
2016-05-12 | 2016-03-31 | -0.08 | -0.1 | -0.02 | 25 | ||
2016-02-25 | 2015-12-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2015-11-12 | 2015-09-30 | -0.1 | -0.09 | 0.01 | 10 | ||
2015-08-06 | 2015-06-30 | -0.1 | -0.08 | 0.02 | 20 | ||
2015-05-07 | 2015-03-31 | -0.09 | -0.09 | 0.0 | 0 | ||
2015-03-12 | 2014-12-31 | -0.07 | -0.08 | -0.01 | 14 | ||
2014-11-06 | 2014-09-30 | -0.05 | -0.07 | -0.02 | 40 | ||
2014-08-07 | 2014-06-30 | -0.04 | -0.07 | -0.03 | 75 | ||
2014-05-08 | 2014-03-31 | -0.04 | -0.1004 | -0.0604 | 151 |
Use BioLife Solutions in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLife Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Solutions will appreciate offsetting losses from the drop in the long position's value.BioLife Solutions Pair Trading
BioLife Solutions Pair Trading Analysis
The ability to find closely correlated positions to BioLife Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLife Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLife Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLife Solutions to buy it.
The correlation of BioLife Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLife Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLife Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLife Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioLife Solutions position
In addition to having BioLife Solutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 22 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.